This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

BILD2 and BILIRUBIN TOTAL GEN.3 (2016-07-20)

Starting date:
July 20, 2016
Posting date:
August 10, 2016
Type of communication:
Medical Device Recall
Subcategory:
Medical Device
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Medical Devices
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-59742

Affected products

A. BILD2 (DIRECT BILIRUBIN GEN.2)

B. BILIRUBIN TOTAL GEN.3 (BILT3)

Reason

This recall/product correction is related to a new drug interference that was identified for Indocynanine Green (ICG) in all direct and total bilirubin tests performed on Roche platforms (cobas c. COBAS INTEGRA, and modular p systems).

Affected products

A. BILD2 (DIRECT BILIRUBIN GEN.2)

Lot or serial number

All lots

Model or catalog number
  • 05168384190
  • 05589037190
  • 05589061190
  • 05589134190
Companies
Manufacturer

Roche Diagnostics GMBH

Sandhoferstrasse 116

Mannheim

68305

GERMANY



B. BILIRUBIN TOTAL GEN.3 (BILT3)

Lot or serial number

All lots

Model or catalog number

05795320190

05795338190

05795346190

05795397190

05795419190

05795648190

Companies
Manufacturer

Roche Diagnostics GMBH

Sandhoferstrasse 116

Mannheim

68305

GERMANY